88 related articles for article (PubMed ID: 25158085)
1. N-terminal phosphorylation of parathyroid hormone (PTH) abolishes its receptor activity.
Kumar A; Gopalswamy M; Wishart C; Henze M; Eschen-Lippold L; Donnelly D; Balbach J
ACS Chem Biol; 2014 Nov; 9(11):2465-70. PubMed ID: 25158085
[TBL] [Abstract][Full Text] [Related]
2. Agonist-dependent phosphorylation of the parathyroid hormone/parathyroid hormone-related peptide receptor.
Qian F; Leung A; Abou-Samra A
Biochemistry; 1998 May; 37(18):6240-6. PubMed ID: 9572838
[TBL] [Abstract][Full Text] [Related]
3. Receptors specific for the carboxyl-terminal region of parathyroid hormone on bone-derived cells: determinants of ligand binding and bioactivity.
Divieti P; Geller AI; Suliman G; Jüppner H; Bringhurst FR
Endocrinology; 2005 Apr; 146(4):1863-70. PubMed ID: 15625242
[TBL] [Abstract][Full Text] [Related]
4. β-catenin regulates parathyroid hormone/parathyroid hormone-related protein receptor signals and chondrocyte hypertrophy through binding to the intracellular C-terminal region of the receptor.
Yano F; Saito T; Ogata N; Yamazawa T; Iino M; Chung UI; Kawaguchi H
Arthritis Rheum; 2013 Feb; 65(2):429-35. PubMed ID: 23124878
[TBL] [Abstract][Full Text] [Related]
5. Parathyroid Hormone Senses Extracellular Calcium To Modulate Endocrine Signaling upon Binding to the Family B GPCR Parathyroid Hormone 1 Receptor.
Culhane KJ; Belina ME; Sims JN; Cai Y; Liu Y; Wang PSP; Yan ECY
ACS Chem Biol; 2018 Aug; 13(8):2347-2358. PubMed ID: 29952553
[TBL] [Abstract][Full Text] [Related]
6. Cooperative interaction of arginine-19 and the N-terminal signaling domain in the affinity and potency of parathyroid hormone.
Tsomaia N; Shimizu M; Shimizu N; Gardella TJ; Mierke DF
Biochemistry; 2004 Mar; 43(12):3459-70. PubMed ID: 15035617
[TBL] [Abstract][Full Text] [Related]
7. Structure-function relationship studies of PTH(1-11) analogues containing D-amino acids.
Caporale A; Biondi B; Schievano E; Wittelsberger A; Mammi S; Peggion E
Eur J Pharmacol; 2009 Jun; 611(1-3):1-7. PubMed ID: 19303868
[TBL] [Abstract][Full Text] [Related]
8. Parathyroid hormone (PTH) and PTH-related peptide domains contributing to activation of different PTH receptor-mediated signaling pathways.
Cupp ME; Nayak SK; Adem AS; Thomsen WJ
J Pharmacol Exp Ther; 2013 Jun; 345(3):404-18. PubMed ID: 23516330
[TBL] [Abstract][Full Text] [Related]
9. Design, conformational studies and analysis of structure-function relationships of PTH (1-11) analogues: the essential role of Val in position 2.
Caporale A; Gesiot L; Sturlese M; Wittelsberger A; Mammi S; Peggion E
Amino Acids; 2012 Jul; 43(1):207-18. PubMed ID: 21918876
[TBL] [Abstract][Full Text] [Related]
10. A salt bridge between Arg-20 on parathyroid hormone (PTH) and Asp-137 on the PTH1 receptor is essential for full affinity.
Weaver RE; Wigglesworth MJ; Donnelly D
Peptides; 2014 Nov; 61():83-7. PubMed ID: 25218037
[TBL] [Abstract][Full Text] [Related]
11. Bioactive N-terminal undecapeptides derived from parathyroid hormone: the role of alpha-helicity.
Barazza A; Wittelsberger A; Fiori N; Schievano E; Mammi S; Toniolo C; Alexander JM; Rosenblatt M; Peggion E; Chorev M
J Pept Res; 2005 Jan; 65(1):23-35. PubMed ID: 15686531
[TBL] [Abstract][Full Text] [Related]
12. Parathyroid hormone and parathyroid hormone-related peptide, and their receptors.
Gensure RC; Gardella TJ; Jüppner H
Biochem Biophys Res Commun; 2005 Mar; 328(3):666-78. PubMed ID: 15694400
[TBL] [Abstract][Full Text] [Related]
13. Discovery of a small molecule antagonist of the parathyroid hormone receptor by using an N-terminal parathyroid hormone peptide probe.
Carter PH; Liu RQ; Foster WR; Tamasi JA; Tebben AJ; Favata M; Staal A; Cvijic ME; French MH; Dell V; Apanovitch D; Lei M; Zhao Q; Cunningham M; Decicco CP; Trzaskos JM; Feyen JH
Proc Natl Acad Sci U S A; 2007 Apr; 104(16):6846-51. PubMed ID: 17428923
[TBL] [Abstract][Full Text] [Related]
14. Toward parathyroid hormone minimization: conformational studies of cyclic PTH(1-14) analogues.
Tsomaia N; Pellegrini M; Hyde K; Gardella TJ; Mierke DF
Biochemistry; 2004 Jan; 43(3):690-9. PubMed ID: 14730973
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a novel cell-based assay for potency determination of human parathyroid hormone (PTH).
Hohenstein A; Hebell M; Zikry H; El Ghazaly M; Mueller F; Rohde J
J Pharm Biomed Anal; 2014 Sep; 98():345-50. PubMed ID: 24996007
[TBL] [Abstract][Full Text] [Related]
16. Progress, paradox, and potential: parathyroid hormone research over five decades.
Potts JT; Gardella TJ
Ann N Y Acad Sci; 2007 Nov; 1117():196-208. PubMed ID: 18056044
[TBL] [Abstract][Full Text] [Related]
17. A tagged parathyroid hormone derivative as a carrier of antibody cargoes transported by the G protein coupled PTH1 receptor.
Charest-Morin X; Fortin JP; Lodge R; Allaeys I; Poubelle PE; Marceau F
Peptides; 2014 Oct; 60():71-9. PubMed ID: 25128082
[TBL] [Abstract][Full Text] [Related]
18. Structural characterization of the parathyroid hormone receptor domains determinant for ligand binding.
Mierke DF; Mao L; Pellegrini M; Piserchio A; Plati J; Tsomaia N
Biochem Soc Trans; 2007 Aug; 35(Pt 4):721-3. PubMed ID: 17635133
[TBL] [Abstract][Full Text] [Related]
19. The parathyroid hormone receptorsome and the potential for therapeutic intervention.
Mahon MJ
Curr Drug Targets; 2012 Jan; 13(1):116-28. PubMed ID: 21777186
[TBL] [Abstract][Full Text] [Related]
20. Regions in rat and human parathyroid hormone (PTH) 2 receptors controlling receptor interaction with PTH and with antagonist ligands.
Goold CP; Usdin TB; Hoare SR
J Pharmacol Exp Ther; 2001 Nov; 299(2):678-90. PubMed ID: 11602681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
